Haloperidol Decanoate Injection
FDA Label NDC 0143-9295

42 label sections · Submitted to the FDA by Hikma Pharmaceuticals Usa Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Hikma Pharmaceuticals Usa Inc. for the product Haloperidol Decanoate (NDC 0143-9295). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: increased mortality in elderly patients with dementia-related psychosis, 1 indications and usage, 2.1 recommended dosage and administration, 2.2 recommended supplemental immediate-release oral haloperidol therapy, 2.3  preparation instructions, 3 dosage forms and strengths, 4 contraindications, 5.1 increased mortality in elderly patients with dementia-related psychosis, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.